Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis

Schizophrenia Research

Volumn 134, Issue 2-3, 2012, Pages 253-259

  Smith, Geoffrey N ^a,b   Thornton, Allen E ^b   Lang, Donna J ^a   MacEwan, G William ^a,c   Ehmann, Thomas S ^a   Kopala, Lili C ^a,c   Tee, Karen ^c   Shiau, Gillian ^a   Voineskos, Aristotle N ^d   Kennedy, James L ^d   Honer, William G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c South Fraser Early Psychosis Program   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

BDNF; First episode psychosis; Hippocampus; Schizophrenia

Indexed keywords

METHIONINE; NEUROLEPTIC AGENT; VALINE;

ADOLESCENT; ADULT; AGE; ALLELE; ARTICLE; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; BRAIN SIZE; CANNABIS ADDICTION; CATCHMENT; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FIRST EPISODE PSYCHOSIS; FOLLOW UP; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIPPOCAMPAL VOLUME; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; PRIORITY JOURNAL; PSYCHOSIS; VOLUNTEER;

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION DISORDERS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; METHIONINE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; VALINE; YOUNG ADULT;

EID: 84856255919     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.11.022     Document Type: Article

References (66)

1. Agartz I., Sedvall G.C., Terenius L., Kulle B., Frigessi A., Hall H., Jonsson E.G. BDNF gene variants and brain morphology in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B:513-523.
2. Alexander N., Osinsky R., Schmitz A., Mueller E., Kuepper Y., Hennig J. The BDNF Val66Met polymorphism affects HPA-axis reactivity to acute stress. Psychoneuroendocrinology 2010, 35:949-953.
3. Baare W.F.C., van Oel C.J., Hulshoff H.E., Schnack H.G., Durston S., Sitskoorn M.M., Kahn R.S. Volumes of brain structures in twins discordant for schizophrenia. Arch. Gen. Psychiatry 2001, 58:33-40.
4. Blair J.R., Spreen O. Predicting premorbid IQ: a revision of the National Adult Reading Test. Neuropsychology 1989, 3:129-136.
5. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 2008, 11:1169-1180.
6. Bueller J.A., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., Zubieta J.K. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol. Psychiatry 2006, 59:812-815.
7. Casey B.J., Glatt C.E., Tottenham N., Soliman F., Bath K., Amso D., Altemus M., Pattwell S., Jones R., Levita L., McEwen B., Magarinos A.M., Gunnar M., Thomas K.M., Mezey J., Clark A.G., Hempstead B.L., Lee F.S. Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development. Neurosci. Lett. 2009, 164:108-120.
8. Chen Z.Y., Patel P.D., Sant G., Meng C.X., Teng K.K., Hempstead B.L., Lee F.S. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 2004, 24:4401-4411.
9. Chepenik L.G., Fredericks C., Papademetris X., Spencer L., Lacadie C., Wang F., Pittman B., Duncan J.S., Staib L.H., Duman R.S., Gelernter J., Blumberg H.P. Effects of the brain-derived neurotrophic growth factor Val66Met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology 2009, 34:944-951.
10. Dempster E., Toulopoulou T., McDonald C., Bramon E., Walshe M., Filbey F., Wickham H., Sham P.C., Murray R.M., Collier D.A. Association between BDNF Val66Met genotype and episodic memory. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 134:73-75.
11. Dutt A., McDonald C., Dempster E., Prata D., Shaikh M., Williams I., Schulze K., Marshall N., Walshe M., Allin M., Collier D., Murray R.M., Bramon E. The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. Psychol. Med. 2009, 39:1783-1797.
12. Ebner F., Tepest R., Dani I., Pfeiffer U., Schulze T.G., Rietschel M., Maier W., Traber F., Block W., Schild H.H., Wagner M., Steinmetz H., Gaebel W., Honer W.G. The hippocampus in families with schizophrenia in relation to obstetric complications. Schizophr. Res. 2008, 104:71-78.
13. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
14. Erickson K.I., Prakash R.S., Voss M.W., Chaddock L., Heo S., McLaren M., Pence B.D., Martin S.A., Vieira V.J., Woods J.A., McAuley E., Kramer A.F. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J. Neurosci. 2010, 30:5368-5375.
15. Fischl B., Salat D., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
16. Gallinat J., Schubert F., Bruhl R., Hellweg R., Klar A.A., Kehrer C., Wirth C., Sander T., Lang U.E. Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex. NeuroImage 2010, 49:767-771.
17. Geuze E., Vermettenand E., Bremner J.D. MR-based in vivo hippocampal volumetrics: 2. findings in neuropsychiatric disorders. Mol. Psychiatry 2005, 10:160-184.
18. Goldberg T.E., Iudicello J., Russo C., Elvevag B., Straub R., Egan M.F., Weinberger D.R. BDNF Val66Met polymorphism significantly affects d' in verbal recognition memory at short and long delays. Biol. Psychiatry 2008, 77:20-24.
19. Gomez A., Escobar M.L. In vivo BDNF modulation of adult functional and morphological synaptic plasticity at hippocampal mossy fibers. Neurosci. Lett. 2008, 445:62-67.
20. Gratacos M., Gonzalez J.R., Mercader J.M., de Cid R., Urretavizcaya M., Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol. Psychiatry 2007, 61:911-922.
21. Green M.J., Matheson S.L., Shepherd A., Weickert C.S., Carr V.J. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol. Psychiatry 2010, 15:1-13.
22. Gur R.E., Turetsky B.I., Cowell P.E., Finkelman C., Maany V., Grossman R.I., Arnold S.E., Bilker W.B., Gur R.C. Temporolimbic volume reductions in schizophrenia. Arch. Gen. Psychiatry 2000, 57:769-775.
23. Hall D., Dhilla A., Charalambous A., Gogos J.A., Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am. J. Hum. Genet. 2003, 73:370-376.
24. Hall J., Whalley H.C., Marwick K., McKirdy J., Sussmann J., Romaniuk L., Johnstone E.C., Wan H.I., McIntosh A.M., Lawrie S.M. Hippocampal function in schizophrenia and bipolar disorder. Psychol. Med. 2010, 40:761-770.
25. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., Weinberger D.R. Brain-derived neurotrophic factor Val66Met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 2003, 23:6690-6694.
26. Hemmings S.M., Kinnear C.J., Van der Merwe L., Lochner C., Corfield V.A., Moolman-Smook J.C., Stein D.J. Investigating the role of the brain-derived neurotrophic factor (BDNF) Val66Met variant in obsessive-compulsive disorder. World J. Biol. Psychiatry 2008, 9:126-134.
27. Jessen F., Schuhmacher A., vonWiddern O., Guttenthaler V., Hofels S., Suliman H., Scheef L., Block W., Urbach H., Maier W., Zobel A. No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression. Psychiatr. Genet. 2009, 19:99-101.
28. Jiang X., Xu K., Hoberman J., Tian F., Marko A.J., Waheed J.F., Harris C.R., Marini A.M., Enoch M.A., Lipsky R.H. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 2005, 30:1353-1361.
29. Joffe R.T., Gatt J.M., Kemp A.H., Grieve S., Dobson-Stone C., Kuan S.A., Schofield P.R., Gordon E., Williams L.M. Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: implications for depressive illness. Hum. Brain Mapp. 2009, 30:1246-1256.
30. Kaufman J., Yang B.Z., Douglas-Palumberi H., Grasso D., Lipschitz D., Houshyar S., Krystal J.H., Gelernter J. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol. Psychiatry 2006, 59:673-680.
31. Kawashima K., Ikeda M., Kishi T., Kitajima T., Yamanouchi Y., Kinoshita Y., Okochi T., Aleksic B., Tomita M., Okada T., Kunugi H., Inada T., Ozaki N., Iwata N. BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis. Schizophr. Res. 2009, 112:72-79.
32. Kleim J.A., Chan S., Pringle E., Schallert K., Procaccio V., Jimenez R., Cramer S.C. BDNF Val66Met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat. Neurosci. 2006, 9:735-737.
33. Koolschijn P.C., van Haren N.E., Bakker S.C., Hoogendoorn M.L., Hulshoff Pol H.E., Kahn R.S. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Hippocampus 2010, 20:1010-1017.
34. Krueger F., Pardini M., Huey E.D., Raymont V., Solomon J., Lipsky R.H., Hodgkinson C.A., Goldman D., Grafman J. The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injury. J. Neurosci. 2011, 31:598-606.
35. Lang U.E., Hellweg R., Kalus P., Bajbouj M., Lenzen K.P., Sander T., Kunz D., Gallinat J. Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology 2005, 180:95-99.
36. Lang U.E., Hellweg R., Seifert F., Schubert F., Gallinat J. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol. Psychiatry 2007, 62:530-535.
37. Leuner B., Gould E. Structural plasticity and hippocampal function. Annu. Rev. Psychol. 2010, 61:111-140.
38. Lipsky R.H., Marini A.M. Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann. N. Y. Acad. Sci. 2007, 1122:130-143.
39. MacQueen G., Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?. Mol. Psychiatry 2011, 16:252-264.
40. Mata J., Thompson R.J., Gotlib I.H. BDNF genotype moderates the relation between physical activity and depressive symptoms. Health Psychol. 2010, 29:130-133.
41. Mill J., Tang T., Kaminsky Z., Khare T., Yazdanpanah S., Bouchard L., Jia P., Assadzadeh A., Flanagan J., Schumacher A., Wang S.C., Petronis A. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet. 2008, 82:696-711.
42. Nemoto K., Ohnishi T., Mori T., Moriguchi Y., Hashimoto R., Asada T., Kunugi H. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci. Lett. 2006, 397:25-29.
43. Petryshen T.L., Sabeti P.C., Aldinger K.A., Fry B., Fan J.B., Schaffner S.F., Waggoner S.G., Tahl A.R., Sklar P. Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Mol. Psychiatry 2010, 15:810-815.
44. Rais M., Cahn W., Van Haren N., Schnack H., Caspers E., Hulshoff Pol H., Kahn R. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am. J. Psychiatry 2008, 165:490-496.
45. Rizos E.N., Papathanasiou M., Michalopoulou P.G., Mazioti A., Douzenis A., Kastania A., Nikolaidou P., Laskos E., Vasilopoulou K., Lykouras L. Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients. Schizophr. Res. 2011, 129:201-204.
46. Rutten B.P., Mill J. Epigenetic mediation of environmental influences in major psychotic disorders. Schizophr. Bull. 2009, 35:1045-1056.
47. Sambataro F., Murty V.P., Lemaitre H.S., Reed J.D., Das S., Goldberg T.E., Callicott J.H., Weinberger D.R., Mattay V.S. BNDF modulates normal human hippocampal aging. Mol. Psychiatry 2010, 15:116-121.
48. Sen S., Nesse R.M., Stoltenberg S.F., Li S., Gleiberman L., Chakravarti A., Weder A.B., Burmeister M. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 2003, 28:397-401.
49. Shalev I., Lerer E., Israel S., Uzefovsky F., Gritsenko I., Mankuta D., Ebstein R.P., Kaitz M. BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuroendocrinology 2009, 34:382-388.
50. Shoval G., Weizman A. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur. Neuropsychopharmacol. 2005, 15:319-329.
51. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155.
52. Steen R.G., Mill C., McClure R., Hamer R.M., Lieberman J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 2006, 188:510-518.
53. Stern A.J., Savostyanova A.A., Goldman A., Barnett A.S., van der Veen J.W.C., Callicott J.H., Mattay V.S., Weinberger D.R., Marenco S. Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla. Biol. Psychiatry 2008, 64:856-862.
54. Szeszko P.R., Strous R.D., Goldman R.S., Ashtari M., Knuth K.H., Lieberman J.A., Bilder R.M. Neuropsychological correlates of hippocampal volumes in patients experiencing a first episode of schizophrenia. Am. J. Psychiatry 2002, 159:217-226.
55. Szeszko P.R., Lipsky R., Mentschel C., Robinson D., Gunduz-Bruce H., Sevy S., Ashtari M., Napolitano B., Bilder R.M., Kane J.M., Goldman D., Malhotra A.K. Brain-derived neurotrophic factor Val66Met polymorphism and volume of the hippocampal formation. Mol. Psychiatry 2005, 10:631-636.
56. Szeszko P.R., Robinson D.G., Sevy S., Kumra S., Rupp C.I., Betensky J.D., Lencz T., Ashtari M., Kane J.M., Malhotra A.K., Gunduz-Bruce H., Napolitano B., Bilder R.M. Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. Br. J. Psychiatry 2007, 190:230-236.
57. Takahashi T., Suzuki M., Tsunoda M., Kawamura Y., Takahashi N., Tsuneki H., Kawasaki Y., Zhou S.Y., Kobayashi S., Sasaoka T., Seto H., Kurachi M., Ozaki N. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neurosci. Lett. 2008, 435:34-39.
58. Tamminga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. Am. J. Psychiatry 2010, 167:1178-1193.
59. Thoma R.J., Monnig M., Hanlon F.M., Miller G.A., Petropoulos H., Mayer A.R., Yeo R., Euler M., Lysne P., Moses S.N., Canive J.M. Hippocampus volume and episodic memory in schizophrenia. J. Int. Neuropsychol. Soc. 2009, 15:182-195.
60. van Erp T.G., Saleh P.A., Huttunen M., Lonnqvist J., Kaprio J., Salonen O., Valanne L., Poutanen V.P., Standertskjold-Nordenstam C.G., Cannon T.D. Hippocampal volumes in schizophrenic twins. Arch. Gen. Psychiatry 2004, 61:346-353.
61. van Haren N.E.M., Picchioni M.M., McDonald C., Marshall N., Davis N., Ribchester T., Hulshoff Pol H.E., Sharma T., Sham P., Kahn R.S., Murray R.M. A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia. Biol. Psychiatry 2004, 56:454-461.
62. Vita A., DePeri L., Silenzi C., Dieci M. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr. Res. 2006, 82:75-88.
63. Voineskos A.N., Lerch J.P., Felsky D., Shaikh S., Rajji T.K., Miranda D., Lobaugh N.J., Mulsant B.H., Pollock B.G., Kennedy J.L. The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer's disease. Arch. Gen. Psychiatry 2011, 68:198-206.
64. Wechsler D. Wechsler Memory Scale-Third Edition 1997, The Psychological Corporation, San Antonio, Texas.
65. Xu M.Q., St Clair D., Ott J., Feng G.Y., He L. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr. Res. 2007, 91:6-13.
66. Zintzaras E. Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis. Psychiatr. Genet. 2007, 17:69-75.